Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

Data as of Jan 30
 +0.0065 / +1.51%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Mast Therapeutics, Inc. is a biopharmaceutical company that is engaged in developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its lead product MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and thrombosis. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Contact Information

Mast Therapeutics, Inc.
12390 El Camino Real
San Diego California 92130
P:(858) 552-0866
Investor Relations:



Other institutional8.73%
Mutual fund holders10.20%
Individual stakeholders0.27%

Top Executives

Brian M. CulleyChief Executive Officer & Director
Patrick L. KeranPresident, Chief Operating Officer & Secretary
Brandi L. RobertsChief Financial Officer, CAO & Senior VP
Edwin L. ParsleyChief Medical Officer & Senior Vice President
Robert Martin EmanueleSenior Vice President-Development

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.